Authors: Kreitman, RJ Margulies, I Stetler-Stevenson, M Wang, QC FitzGerald, DJP Pastan, I

Citation: Rj. Kreitman et al., Cytotoxic activity of disulfide-stabilized recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) toward fresh malignant cells from patients with B-cell leukemias, CLIN CANC R, 6(4), 2000, pp. 1476-1487

Authors: Kreitman, RJ Wang, QQ FitzGerald, DJP Pastan, I

Citation: Rj. Kreitman et al., Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeys, INT J CANC, 81(1), 1999, pp. 148-155

Authors: Rozemuller, H Terpstra, W Rombouts, EJC Lawler, M Byrne, C FitzGerald, DJP Kreitman, RJ Wielenga, JJ Lowenberg, B Touw, IP Hagenbeek, A Martens, ACM

Citation: H. Rozemuller et al., GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSF, LEUKEMIA, 12(12), 1998, pp. 1962-1970